Lei Wang1, Zixing Wang1, Yuguang Huang2, Yipeng Wang3, Zhong Liu4, Shijie Xin5, Guanghua Lei6, Wei Han1, Xuerong Yu2, Fang Xue1, Yali Chen1, Peng Wu1, Jingmei Jiang1, Xiaochu Yu7. 1. Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/School of Basic Medicine, Peking Union Medical College, Beijing, China. 2. Anaesthesiology Department, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. 3. Orthopaedics Department, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. 4. Clinical Transfusion Research Centre, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China. 5. Vascular and Thyroid Surgery Department, the First Hospital of China Medical University, Shenyang, China. 6. Orthopaedics Department, Xiangya Hospital, Central South University, Changsha, China. 7. Nephrology Department, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Abstract
BACKGROUND: Findings of observational studies investigating the impact of transfusions are at odds with those of randomised controlled trials, raising concern that observational studies may be inappropriate to inform transfusion decisions. We examined whether observational data could replicate evidence from randomised controlled trials on restrictive transfusion in cardiac and orthopaedic surgery, and be generalised to broader specialties as well as to a lower haemoglobin transfusion threshold (7 g/dL). MATERIAL AND METHODS: A multicentre, prospective cohort study was performed at three representative regional hospitals in China between 2015 and 2016. Participants were surgical inpatients (≥18 years; hospital stay ≥24 h) in six specialties: cardiac, cerebral, vascular (CCV), and orthopaedic, general, thoracic (non-CCV). Patients with a stable haemoglobin (7-10 g/dL) constituted the primary analytic sample, while patients with ≥500 mL intra-operative bleeding were analysed separately to avoid haemoglobin instability. The association of transfusion with surgical outcomes (death, in-hospital complications) was evaluated. RESULTS: The transfusion rate was 10.7% in 36,607 patients (mean age, 52.5±14.3 years; 52.3% female). After restriction, stratification, and propensity score matching to reduce patients' heterogeneity, transfusion was unrelated to death (CCV: odds ratio [OR]=0.74, 95% confidence interval [CI]: 0.16-3.39; non-CCV: OR 0.83, 95% CI: 0.36-1.94) and the composite complication (CCV: OR 1.31, 95% CI: 0.63-2.72; non-CCV: OR=1.24, 95% CI: 0.81-1.90). The results were consistent in subgroups (elderly, coronary heart disease, malignant tumour, severe illness) and applicable to patients with significant bleeding after restoration of a stable haemoglobin. DISCUSSION: Transfusion at a stable haemoglobin concentration of 7-10 g/dL did not alter surgical outcomes. Our results show the feasibility of observational data to expand restrictive transfusion to broader specialties and a lower transfusion threshold in surgical practice.
BACKGROUND: Findings of observational studies investigating the impact of transfusions are at odds with those of randomised controlled trials, raising concern that observational studies may be inappropriate to inform transfusion decisions. We examined whether observational data could replicate evidence from randomised controlled trials on restrictive transfusion in cardiac and orthopaedic surgery, and be generalised to broader specialties as well as to a lower haemoglobin transfusion threshold (7 g/dL). MATERIAL AND METHODS: A multicentre, prospective cohort study was performed at three representative regional hospitals in China between 2015 and 2016. Participants were surgical inpatients (≥18 years; hospital stay ≥24 h) in six specialties: cardiac, cerebral, vascular (CCV), and orthopaedic, general, thoracic (non-CCV). Patients with a stable haemoglobin (7-10 g/dL) constituted the primary analytic sample, while patients with ≥500 mL intra-operative bleeding were analysed separately to avoid haemoglobin instability. The association of transfusion with surgical outcomes (death, in-hospital complications) was evaluated. RESULTS: The transfusion rate was 10.7% in 36,607 patients (mean age, 52.5±14.3 years; 52.3% female). After restriction, stratification, and propensity score matching to reduce patients' heterogeneity, transfusion was unrelated to death (CCV: odds ratio [OR]=0.74, 95% confidence interval [CI]: 0.16-3.39; non-CCV: OR 0.83, 95% CI: 0.36-1.94) and the composite complication (CCV: OR 1.31, 95% CI: 0.63-2.72; non-CCV: OR=1.24, 95% CI: 0.81-1.90). The results were consistent in subgroups (elderly, coronary heart disease, malignant tumour, severe illness) and applicable to patients with significant bleeding after restoration of a stable haemoglobin. DISCUSSION: Transfusion at a stable haemoglobin concentration of 7-10 g/dL did not alter surgical outcomes. Our results show the feasibility of observational data to expand restrictive transfusion to broader specialties and a lower transfusion threshold in surgical practice.
Authors: C David Mazer; Richard P Whitlock; Dean A Fergusson; Judith Hall; Emilie Belley-Cote; Katherine Connolly; Boris Khanykin; Alexander J Gregory; Étienne de Médicis; Shay McGuinness; Alistair Royse; François M Carrier; Paul J Young; Juan C Villar; Hilary P Grocott; Manfred D Seeberger; Stephen Fremes; François Lellouche; Summer Syed; Kelly Byrne; Sean M Bagshaw; Nian C Hwang; Chirag Mehta; Thomas W Painter; Colin Royse; Subodh Verma; Gregory M T Hare; Ashley Cohen; Kevin E Thorpe; Peter Jüni; Nadine Shehata Journal: N Engl J Med Date: 2017-11-12 Impact factor: 91.245
Authors: M Jawad Latif; Kay See Tan; Daniela Molena; James Huang; Matthew J Bott; Bernard J Park; Prasad S Adusumilli; Valerie W Rusch; Manjit S Bains; Robert J Downey; David R Jones; James M Isbell Journal: J Thorac Cardiovasc Surg Date: 2019-02-12 Impact factor: 5.209
Authors: Keyvan Karkouti; Duminda N Wijeysundera; Terrence M Yau; Stuart A McCluskey; Christopher T Chan; Pui-Yuen Wong; W Scott Beattie Journal: Anesthesiology Date: 2011-09 Impact factor: 7.892
Authors: Dhaval Kolte; Charles Beale; Herbert D Aronow; Kevin F Kennedy; Eirini Apostolidou; Frank W Sellke; Barry L Sharaf; Paul C Gordon; J Dawn Abbott; Afshin Ehsan Journal: J Thorac Cardiovasc Surg Date: 2019-03-28 Impact factor: 5.209
Authors: Jeffrey L Carson; Maria Mori Brooks; J Dawn Abbott; Bernard Chaitman; Sheryl F Kelsey; Darrell J Triulzi; Vankeepuram Srinivas; Mark A Menegus; Oscar C Marroquin; Sunil V Rao; Helaine Noveck; Elizabeth Passano; Regina M Hardison; Thomas Smitherman; Tudor Vagaonescu; Neil J Wimmer; David O Williams Journal: Am Heart J Date: 2013-04-08 Impact factor: 4.749
Authors: Jeffrey L Carson; Simon J Stanworth; John H Alexander; Nareg Roubinian; Dean A Fergusson; Darrell J Triulzi; Shaun G Goodman; Sunil V Rao; Carolyn Doree; Paul C Hebert Journal: Am Heart J Date: 2018-04-07 Impact factor: 4.749
Authors: Jeffrey M Rohde; Derek E Dimcheff; Neil Blumberg; Sanjay Saint; Kenneth M Langa; Latoya Kuhn; Andrew Hickner; Mary A M Rogers Journal: JAMA Date: 2014-04-02 Impact factor: 56.272
Authors: Thomas G Weiser; Alex B Haynes; George Molina; Stuart R Lipsitz; Micaela M Esquivel; Tarsicio Uribe-Leitz; Rui Fu; Tej Azad; Tiffany E Chao; William R Berry; Atul A Gawande Journal: Bull World Health Organ Date: 2016-03-01 Impact factor: 9.408